Last reviewed · How we verify
Saline 0.9% (matching placebo) — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Saline 0.9% (matching placebo) (Saline 0.9% (matching placebo)) — Insel Gruppe AG, University Hospital Bern. Saline 0.9% is an isotonic sodium chloride solution that serves as a physiologically inert vehicle for drug delivery or fluid replacement.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Saline 0.9% (matching placebo) TARGET | Saline 0.9% (matching placebo) | Insel Gruppe AG, University Hospital Bern | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Saline 0.9% (matching placebo) CI watch — RSS
- Saline 0.9% (matching placebo) CI watch — Atom
- Saline 0.9% (matching placebo) CI watch — JSON
- Saline 0.9% (matching placebo) alone — RSS
Cite this brief
Drug Landscape (2026). Saline 0.9% (matching placebo) — Competitive Intelligence Brief. https://druglandscape.com/ci/saline-0-9-matching-placebo. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab